Evaluating the link between stem cells and breast cancer

References

• Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development110, 1001–1020 (1990).
   PubMed Web of Science ®Google Scholar
• Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34 low/negative stem cell. Science273, 242–245 (1996).
   PubMed Web of Science ®Google Scholar
• Janes SM, Lowell S, Hutter C. Epidermal stem cells. J. Pathol.197, 479–491 (2002).
   PubMedGoogle Scholar
• Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays24, 91–98 (2002).
   PubMed Web of Science ®Google Scholar
• Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature439(7072), 84–88 (2006).
   PubMed Web of Science ®Google Scholar
• Stingl J, Eirew P, Ricketson I et al. Purification and unique properties of mammary epithelial stem cells. Nature439(7079), 993–997 (2006).
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med.3(7), 730–737 (1997).
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer and cancer stem cells. Nature414(6859), 105–111 (2001).
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA100(7), 3983–3988 (2003).
   PubMed Web of Science ®Google Scholar
• Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/cell progenitors. Cancer Res.65(13), 5506–5511 (2005).
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumours. Cancer Res.63(18), 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. J. Cell Sci.118, 3585–3594 (2005).
   PubMed Web of Science ®Google Scholar
• DeOme KB, Faulkin LJJ, Bern HA, Blair PB. Development of mammary tumours from hyperplastiv alveolar nodules transplanted into gland-free mammary fat pads of female CH3 mice. Cancer Res.19(5), 515–520 (1959).
   PubMed Web of Science ®Google Scholar
• Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development125(10), 1921–1930 (1998).
   PubMed Web of Science ®Google Scholar
• Chepko G, Smith GH. Three division-competent, structurally distinct cell populations contribute to mammary epithelial renewal. Tissue Cell29(2), 239–253 (1997).
   Google Scholar
• Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res.39, 21–31 (1996).
   Google Scholar
• Diallo R, Schaefer KL, Poremba C et al. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J. Pathol.193(1), 27–32 (2001).
   PubMed Web of Science ®Google Scholar
• Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science274(5295), 2057–2059 (1996).
   PubMed Web of Science ®Google Scholar
• Smith GH, Strickland P, Daniel CW. Putative epithelial stem cell loss corresponds with mammary growth senescence. Cell Tissue Res.10(3), 313–320 (2002).
   Google Scholar
• Welm BE, Tepera SB, Venezia T et al. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol.245(1), 42–56 (2002).
   PubMedGoogle Scholar
• Smith GH. Label-retaining epithelial cells in the mammary gland divide asymmetrically and retain their template DNA strands. Development132(4), 681–687 (2005).
   PubMed Web of Science ®Google Scholar
• Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine haematopoietic stem cells that are replicating in vivo. J. Exp. Med.183(4), 1797–1806 (1996).
   PubMed Web of Science ®Google Scholar
• Alvi AJ, Clayton H, Joshi C et al. Functional and molecular characterization of mammary side population cells. Breast Cancer Res.5(1), R1–8 (2003).
   PubMed Web of Science ®Google Scholar
• Clarke RB, Spence K, Anderson E et al. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol.277(2), 443–456 (2005).
   PubMed Web of Science ®Google Scholar
• Clayton H, Titley I, Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp. Cell Res.297(2), 444–460 (2004).
   Google Scholar
• Dontu G, Abdallah WM, Foley JM et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev.17(10), 1253–1270 (2003).
   PubMed Web of Science ®Google Scholar
• Muschler J, Lochter A, Roskelley CD, Yurchenco P, Bissel MJ. Division of labor among the α6β4 integrin, β1 integrins, and E3 laminin receptor to signal morphogenesis and β-casein expression in mammary epithelial cells. Mol. Biol. Cell10(9), 2817–2828 (1999).
   PubMed Web of Science ®Google Scholar
• Reynolds BA, Weiss S. Clonal and population analyses demonstrate that EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol.175(1), 1–13 (1996).
   PubMed Web of Science ®Google Scholar
• Romanov SR, Kozakiewicz BK, Holst CR et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature409(6820), 633–637 (2001).
   PubMed Web of Science ®Google Scholar
• Weiss S, Dunne C, Hewson J et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci.16(23), 7599–7609 (1996).
   PubMed Web of Science ®Google Scholar
• Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse haematopoietic stem cells. Science241(4861), 58–62 (1988).
   PubMed Web of Science ®Google Scholar
• Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-β1 expression. Oncogene24(4), 552–560 (2005).
   PubMedGoogle Scholar
• Wagner KU, Boulanger CA, Henry MD et al. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development129(6), 1377–1386 (2002).
   PubMedGoogle Scholar
• Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L et al. Evidence for a stem cell hierarchy in the adult human breast. J. Cell Biol.177(1), 87–101 (2007).
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Kripke ML. Metastasis results from pre-existing variant cells within a malignant tumour. Science197(4306), 893–895 (1977).
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science217(4564), 998–1003 (1982).
   PubMed Web of Science ®Google Scholar
• Nowell PC. Mechanisms of tumour progression. Cancer Res.46(5), 2203–2207 (1986).
   PubMed Web of Science ®Google Scholar
• Heppner GH. Tumor heterogeneity. Cancer Res.44(6), 2259–2265 (1984).
   PubMed Web of Science ®Google Scholar
• Weisenthal LM, Lippman ME. Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat. Rep.69(6), 615–632 (1985).
   PubMedGoogle Scholar
• Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science197(4302), 461–463 (1977).
   PubMed Web of Science ®Google Scholar
• Masters JR. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol.1(3), 233–236 (2000).
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature445(7123), 106–110 (2007).
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl Acad. Sci. USA97(13), 7521–7526 (2000).
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell1(5), 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature406(6797), 747–752 (2000).
   PubMed Web of Science ®Google Scholar
• Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA98(19), 10869–10874 (2001).
   PubMed Web of Science ®Google Scholar
• Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA100(14), 8418–8423 (2003).
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret E, Ginestier C, Monville F et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene25(15), 2273–2284 (2006).
   PubMed Web of Science ®Google Scholar
• Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis. Markers17(2), 99–109 (2001).
   Google Scholar
• Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif.36(Suppl. 1), 59–72 (2003).
   PubMed Web of Science ®Google Scholar
• Dontu G, El-Ashry D, Wicha MS. Breast cancer stem/progenitor cells and the estrogen receptor. Trends Endocrinol. Metab.15(5), 193–197 (2004).
   PubMed Web of Science ®Google Scholar
• Cariati M, Naderi A, Brown JP et al. A-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int. J. Cancer122(2), 298–304 (2008).
   PubMed Web of Science ®Google Scholar
• Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res.68(7), 2419–2426 (2008).
   PubMed Web of Science ®Google Scholar
• Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res.10(2), R25 (2008).
   PubMed Web of Science ®Google Scholar
• Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl Cancer Inst.98(24), 1777–1785 (2006).
   PubMed Web of Science ®Google Scholar
• Balic M, Lin H, Young L et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res.12(19), 5615–5621 (2006).
   PubMed Web of Science ®Google Scholar
• Abraham BK, Fritz P, McClellan M et al. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin. Cancer Res.11(3), 1154–1159 (2005).
   PubMed Web of Science ®Google Scholar
• Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest.115(6), 1503–1521 (2005).
   PubMed Web of Science ®Google Scholar
• Shipitsin M, Campbell LL, Argani P et al. Molecular definition of breast tumor heterogeneity. Cancer Cell11(3), 259–273 (2007).
   PubMed Web of Science ®Google Scholar
• Li X, Lewis MT, Huang J et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst.100(9), 672–679 (2008).
   PubMed Web of Science ®Google Scholar
• Aisenberg AC, Finkelstein DM, Doppke KP et al. High risk of breast carcinoma after irradiation of young women with Hodgkin’s disease. Cancer79(6), 1203–1210 (1997).
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Norman JE Jr, Asano M et al. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950–74. J. Natl Cancer Inst.62(6), 1347–1359 (1979).
   PubMed Web of Science ®Google Scholar
• Cariati M, Purushotham AD. Stem cells and breast cancer. Histopathology52(1), 99–107 (2008).
   PubMed Web of Science ®Google Scholar
• Wright MH, Calcagno AM, Salcido CD et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res.10(1), R10 (2008).
   PubMed Web of Science ®Google Scholar
• Liu S, Ginestier C, Charafe-Jauffret E et al.BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl Acad. Sci. USA105(5), 1680–1685 (2008).
   PubMedGoogle Scholar
• van’t Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature415(6871), 530–536 (2002).
   PubMed Web of Science ®Google Scholar
• Costello RT, Mallet F, Gaugler B et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res.60(16), 4403–4411 (2000).
   PubMed Web of Science ®Google Scholar
• Korkaya H, Wicha MS. Selective targeting of cancer stem cells: a new concept in cancer therapeutics. BioDrugs21, 299–310 (2007).
   PubMed Web of Science ®Google Scholar
• Norgaard JM, Olesen LH, Hokland P. Changing picture of cellular drug resistance in human leukemia. Crit. Rev. Oncol. Hematol.50(1), 39–49 (2004).
   PubMed Web of Science ®Google Scholar
• Doyle LA, Yang W, Abruzzo LV et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sci. USA95(26), 15665–15670 (1998).
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling and cancer. Genes Dev.14(15), 1837–1851 (2000).
   PubMed Web of Science ®Google Scholar
• Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science296(5573), 1644–1646 (2002).
   PubMed Web of Science ®Google Scholar
• Klopocki E, Kristiansen G, Wild PJ et al. Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int. J. Oncol.25(3), 641–649 (2004).
   PubMed Web of Science ®Google Scholar
• Ugolini F, Charafe-Jauffret E, Bardou VJ et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene20(41), 5810–5817 (2001).
   PubMed Web of Science ®Google Scholar
• Tepera SB, McCrea PD, Rosen JM. A β-catenin survival signal is required for normal lobular development in the mammary gland. J. Cell Sci.116(Pt 6), 1137–1149 (2003).
   PubMed Web of Science ®Google Scholar
• Gunther EJ, Moody SE, Belka GK et al. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev.17(4), 488–501 (2003).
   PubMed Web of Science ®Google Scholar
• Brennan K, Brown AM. Is there a role for Notch signalling in human breast cancer? Breast Cancer Res.5(2), 69–75 (2003).
   Google Scholar
• Soriano JV, Uyttendaele H, Kitajewski J, Montesano R. Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro. Int. J. Cancer86(5), 652–659 (2000).
   PubMedGoogle Scholar
• Behbod F, Rosen JM. Will cancer stem cells provide new therapeutic targets? Carcinogenesis26(4), 703–711 (2005).
   PubMed Web of Science ®Google Scholar
• Dontu G, Jackson KW, McNicholas E et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res.6(6), R605–R615 (2004).
   PubMed Web of Science ®Google Scholar
• Berman DM, Karhadkar SS, Maitra A et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature425(6960), 846–851 (2003).
   PubMed Web of Science ®Google Scholar
• Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer3(12), 903–911 (2003).
   PubMed Web of Science ®Google Scholar
• Kubo M, Nakamura M, Tasaki A et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res.64(17), 6071–6074 (2004).
   PubMed Web of Science ®Google Scholar
• Lewis MT, Ross S, Strickland PA et al. Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development126(22), 5181–5193 (1999).
   PubMed Web of Science ®Google Scholar
• Lewis MT, Ross S, Strickland PA et al. The Gli2 transcription factor is required for normal mouse mammary gland development. Dev. Biol.238(1), 133–144 (2001).
   PubMed Web of Science ®Google Scholar
• Liu S, Dontu G, Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res.66(12), 6063–6071 (2006).
   PubMed Web of Science ®Google Scholar
• Karhadkar SS, Bova GS, Abdallah N et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature431(7009), 707–712 (2004).
   PubMed Web of Science ®Google Scholar
• Romer JT, Kimura H, Magdaleno S et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell6(3), 229–240 (2004).
   PubMed Web of Science ®Google Scholar